These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29981093)
21. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. Solomon L; Flynn C; Muck K; Vertefeuille J J Urban Health; 2004 Mar; 81(1):25-37. PubMed ID: 15047781 [TBL] [Abstract][Full Text] [Related]
23. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. Rotily M; Weilandt C; Bird SM; Käll K; Van Haastrecht HJ; Iandolo E; Rousseau S Eur J Public Health; 2001 Sep; 11(3):243-50. PubMed ID: 11582600 [TBL] [Abstract][Full Text] [Related]
24. Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study. Derks L; Gassowski M; Nielsen S; An der Heiden M; Bannert N; Bock CT; Bremer V; Kücherer C; Ross S; Wenz B; Marcus U; Zimmermann R; Int J Drug Policy; 2018 Sep; 59():54-62. PubMed ID: 30005420 [TBL] [Abstract][Full Text] [Related]
25. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California. Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. Dufour A; Alary M; Poulin C; Allard F; Noël L; Trottier G; Lépine D; Hankins C AIDS; 1996 Aug; 10(9):1009-15. PubMed ID: 8853735 [TBL] [Abstract][Full Text] [Related]
27. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users. Kim AY; Nagami EH; Birch CE; Bowen MJ; Lauer GM; McGovern BH Hepatology; 2013 Mar; 57(3):944-52. PubMed ID: 23111904 [TBL] [Abstract][Full Text] [Related]
28. Viral hepatitis B, C and HIV infection in Croatian prisons. Burek V; Horvat J; Butorac K; Mikulić R Epidemiol Infect; 2010 Nov; 138(11):1610-20. PubMed ID: 20202285 [TBL] [Abstract][Full Text] [Related]
29. Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates. Schulte B; Stöver H; Thane K; Schreiter C; Gansefort D; Reimer J Int J Prison Health; 2009; 5(1):39-44. PubMed ID: 25758928 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. Allwright S; Bradley F; Long J; Barry J; Thornton L; Parry JV BMJ; 2000 Jul; 321(7253):78-82. PubMed ID: 10884256 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis virus and HIV infections in inmates of a state correctional facility in Mexico. Alvarado-Esquivel C; Sablon E; Martínez-García S; Estrada-Martínez S Epidemiol Infect; 2005 Aug; 133(4):679-85. PubMed ID: 16050514 [TBL] [Abstract][Full Text] [Related]
33. Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia. Bick J; Culbert G; Al-Darraji HA; Koh C; Pillai V; Kamarulzaman A; Altice F Int J Prison Health; 2016 Dec; 12(4):253-269. PubMed ID: 27921633 [TBL] [Abstract][Full Text] [Related]
34. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis. Heijnen M; Mumtaz GR; Abu-Raddad LJ J Int AIDS Soc; 2016; 19(1):20873. PubMed ID: 27237131 [TBL] [Abstract][Full Text] [Related]
35. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting. Lafferty L; Rance J; Treloar C Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. Tresó B; Barcsay E; Tarján A; Horváth G; Dencs A; Hettmann A; Csépai MM; Gyori Z; Rusvai E; Takács M J Urban Health; 2012 Feb; 89(1):108-16. PubMed ID: 22143408 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of HIV infection in provincial prisons in British Columbia. Rothon DA; Mathias RG; Schechter MT CMAJ; 1994 Sep; 151(6):781-7. PubMed ID: 8087754 [TBL] [Abstract][Full Text] [Related]
38. Drug injection and HIV prevalence in inmates of Glenochil prison. Gore SM; Bird AG; Burns SM; Goldberg DJ; Ross AJ; Macgregor J BMJ; 1995 Feb; 310(6975):293-6. PubMed ID: 7866170 [TBL] [Abstract][Full Text] [Related]
39. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712 [TBL] [Abstract][Full Text] [Related]
40. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Malliori M; Sypsa V; Psichogiou M; Touloumi G; Skoutelis A; Tassopoulos N; Hatzakis A; Stefanis C Addiction; 1998 Feb; 93(2):243-51. PubMed ID: 9624725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]